Stay current with all the latest and breaking news from healio.com. Compare headlines and media bias behind news outlets on stories breaking today.
healio.com’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.
Information about healio.comWhere is healio.com located?healio.com's Website
FactualityHow credible is the news from healio.com?
Learn more about Factuality Ratings.
Media Bias Ratings
Does healio.com lean left or right?
Learn more about Media Bias Ratings.
Top healio.com News
Politics · New York
Increase in mortality rate among kids, teens largest in decades: research
The country saw the largest increases in the mortality rate in decades among young kids and teenagers in 2020 and 2021, according to a research article released Monday. See the Story
69% Center coverage: 13 sources
Cancer · Washington
FDA sets new guidelines that require mammogram providers to notify about breast density
The Food and Drug Administration released new standards Thursday that could potentially help more women detect breast cancer earlier.See the Story
79% Center coverage: 101 sources
Latest News Stories
Immediate complete revascularization is not inferior to staged procedure for treating multi-vessel disease
In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according to findings from the first large, randomized trial to address this question that is being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology. In staged t…See the Story
100% Center coverage: 2 sources
Coronavirus · New Orleans
Therapeutic-dose anticoagulation may improve COVID-19 outcomes for noncritical inpatients – Healio
A therapeutic vs. prophylactic dose of anticoagulation therapy did not significantly improve outcomes for noncritically ill patients hospitalized with COVID-19. The FREEDOM COVID trial ultimately did not meet its primary endpoint, Valentin Fuster, MD, PhD, said during a late-breaking clinical trials presentation.See the Story
Medical · New Orleans
Addition of sotatercept to existing therapy shows promise for the treatment of pulmonary arterial hypertension
Patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs, who were treated with the novel first-in-class medication sotatercept on top of existing therapy experienced significant improvements in walking distance via a six-minute walking test—the study's primary endpoint and a validated surrogate for functional improvement and reduced symptom burden.See the Story
100% Center coverage: 1 sources
Medical · New Orleans
Bempedoic Acid Cuts CV Events in Statin-Intolerant Patients
Bempedoic acid (Nexletol,Esperion) lowered LDL cholesterol by 21% in the study. The drug was also well-tolerated in the mixed population of primary and secondary prevention patients unable or unwilling to take statins. "These findings establish bempedoic acid as an effective approach to reduce major cardiovascular events in statin-intolerant patients," the study chair concluded.See the Story
Covis Pharma to voluntarily withdraw preterm birth prevention drug from market
Covis Pharma will voluntarily withdraw its preterm birth prevention drug Makena from the market. An FDA advisory committee in October voted to recommend withdrawal due to ineffectiveness. Covis outlined a plan for voluntary withdrawal after the advisory committee hearing to end further proceedings. But the Center for Drug Evaluation and Research did not agree to this proposal.See the Story